Skip to main content
. Author manuscript; available in PMC: 2017 Jan 6.
Published in final edited form as: Small. 2015 Nov 30;12(1):76–82. doi: 10.1002/smll.201502273

Figure 1.

Figure 1

a) SDS page of Doxil® particles after incubation with human serum evidencing the adsorption of complement proteins. b) Nanoparticles that form a protein corona (TTMA and TCOOH, with positive and negative charged respectively) are eliminated faster from the bloodstream comparative to neutral nanoparticles (TEGOH and TZwit). Reproduced with permission from references 23 and 24 respectively.